注意缺陷多动障碍与终生大麻使用:遗传重叠与因果关系
本研究利用注意缺陷多动障碍(ADHD,n=53,293)与终生大麻使用(n=32,330)的最大规模全基因组关联研究(GWAS)荟萃分析汇总统计量,估计两者的遗传相关性并检验因果关系。结果显示遗传相关性为 r2=0.29(P=1.63×10-5),跨性状分析新发现4个全基因组显著位点,两样本孟德尔随机化支持ADHD对终生大麻使用具有因果作用(OR=7.9,95%CI 3.72–15.51,P=5.88×10-5)。
要点
- ADHD与终生大麻使用存在遗传重叠,遗传相关性 r2=0.29(P=1.63×10-5)。
- 孟德尔随机化支持ADHD因果性增加终生大麻使用风险,OR=7.9(95%CI 3.72–15.51)。
- 临床干预ADHD时应关注并评估物质误用风险。
核心结论
- ADHD与终生大麻使用存在部分遗传重叠,且孟德尔随机化分析支持ADHD对终生大麻使用具有因果作用。
- 结果支持ADHD与未来大麻使用之间的时间先后关系,并提示临床干预中需考虑物质误用。
研究设计与样本
- 研究使用ADHD(n=53,293)与终生大麻使用(n=32,330)最大规模GWAS荟萃分析的汇总统计量。
- 方法包括遗传相关性估计、跨性状全基因组关联分析(单变异与基于基因的分析)及两样本孟德尔随机化。
主要发现
- ADHD与终生大麻使用的遗传相关性估计为 r2=0.29(P=1.63×10-5)。
- 跨性状分析新发现4个全基因组显著位点:rs145108385(P=3.30×10-8)、rs4259397(P=4.52×10-8)、WDPCP(P=9.67×10-7)和ZNF251(P=1.62×10-6)。
- 两样本孟德尔随机化显示ADHD个体相较无ADHD个体终生大麻使用的OR为7.9(95%CI 3.72–15.51,P=5.88×10-5)。
关键数值与推荐
- ADHD患病率:儿童青少年5%,成人2.5%。
- ADHD遗传度估计为70–80%,大麻使用起始遗传度为40–48%。
- 遗传相关性 r2=0.29(P=1.63×10-5);ADHD对终生大麻使用因果估计OR=7.9(95%CI 3.72–15.51,P=5.88×10-5)。
临床怎么用
- 对ADHD患者应常规评估大麻等物质使用情况,并将物质误用预防纳入临床干预。
- 鉴于ADHD患病率在儿童青少年为5%、成人为2.5%,早期识别与干预可能有助于降低后续大麻使用风险。
局限性
- 原文摘要未报告本研究的局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Attention-deficit/hyperactivity disorder (ADHD) is a severely impairing neurodevelopmental disorder with a prevalence of 5% in children and adolescents and of 2.5% in adults. Comorbid conditions in ADHD play a key role in symptom progression, disorder course and outcome. ADHD is associated with a significantly increased risk for substance use, abuse and dependence. ADHD and cannabis use are partly determined by genetic factors; the heritability of ADHD is estimated at 70-80% and of cannabis use initiation at 40-48%. In this study, we used summary statistics from the largest available meta-analyses of genome-wide association studies (GWAS) of ADHD (n = 53,293) and lifetime cannabis use (n = 32,330) to gain insights into the genetic overlap and causal relationship of these two traits. We estimated their genetic correlation to be r2 = 0.29 (P = 1.63 × 10-5) and identified four new genome-wide significant loci in a cross-trait analysis: two in a single variant association analysis (rs145108385, P = 3.30 × 10-8 and rs4259397, P = 4.52 × 10-8) and two in a gene-based association analysis (WDPCP, P = 9.67 × 10-7 and ZNF251, P = 1.62 × 10-6). Using a two-sample Mendelian randomization approach we found support that ADHD is causal for lifetime cannabis use, with an odds ratio of 7.9 for cannabis use in individuals with ADHD in comparison to individuals without ADHD (95% CI (3.72, 15.51), P = 5.88 × 10-5). These results substantiate the temporal relationship between ADHD and future cannabis use and reinforce the need to consider substance misuse in the context of ADHD in clinical interventions.
引用
- Soler Artigas M, Sánchez-Mora C, Rovira P, et al. Attention-deficit/hyperactivity disorder and lifetime cannabis use: genetic overlap and causality. Mol Psychiatry. 2019. PMID: 30610198. doi:10.1038/s41380-018-0339-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。